| ECV | CVF | ||||||
---|---|---|---|---|---|---|---|---|
 | Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | ||||
Variables | r value | P value | Standardised β | P value | r value | P value | Standardised β | P value |
Age (years) | −0.032 | 0.888 |  |  | 0.174 | 0.439 |  |  |
Sex (%) | 0.425 | 0.049 | 0.250 | 0.007 | 0.196 | 0.381 | Â | Â |
BMI (kg/m2) | −0.130 | 0.563 |  |  | −0.064 | 0.776 |  |  |
Heart rate (bpm) | −0.199 | 0.374 |  |  | 0.269 | 0.227 |  |  |
Haematocrit (%) | −0.400 | 0.065 |  |  | −0.307 | 0.164 |  |  |
Hypertension (%) | −0.030 | 0.896 |  |  | 0.152 | 0.500 |  |  |
Diabetes mellitus (%) | −0.161 | 0.474 |  |  | 0.086 | 0.704 |  |  |
Hyperlipidaemia (%) | −0.114 | 0.612 |  |  | −0.014 | 0.951 |  |  |
Smoker (%) | −0.370 | 0.090 |  |  | −0.349 | 0.112 |  |  |
Duration (years) | −0.174 | 0.440 |  |  | −0.094 | 0.678 |  |  |
Time between CMR and transplantation (days) | 0.562 | 0.006 | Â | 0.507 | 0.451 | 0.035 | Â | 0.581 |
NT-proBNP (pg/mL) | 0.602 | 0.005 | Â | 0.701 | 0.549 | 0.012 | Â | 0.995 |
LV EF (%) | −0.258 | 0.246 |  |  | −0.126 | 0.576 |  |  |
LV ESVI (mL/m2) | −0.180 | 0.422 |  |  | −0.316 | 0.153 |  |  |
LV EDVI (mL/m2) | −0.258 | 0.246 |  |  | −0.262 | 0.240 |  |  |
LV SVI (mL/m2) | −0.325 | 0.140 |  |  | −0.244 | 0.275 |  |  |
LV cardiac index (L/min/m2) | −0.359 | 0.101 |  |  | −0.320 | 0.146 |  |  |
LV mass index (g/m2) | −0.400 | 0.065 |  |  | −0.234 | 0.295 |  |  |
LV GLS (%) | 0.313 | 0.168 | Â | Â | 0.316 | 0.163 | Â | Â |
LV GCS (%) | 0.381 | 0.088 | Â | Â | 0.282 | 0.215 | Â | Â |
LV GRS (%) | −0.381 | 0.088 |  |  | −0.290 | 0.202 |  |  |
Native T1 time (ms) | – | – |  |  | 0.508 | 0.016 |  | 0.138 |
ECV (%) | – | – |  |  | 0.907 | < 0.001 | 0.911 | < 0.001 |
CVF (%) | 0.907 | < 0.001 | 0.860 | < 0.001 | – | – |  |  |
T2 mapping (ms) | 0.339 | 0.143 | Â | Â | 0.258 | 0.272 | Â | Â |